UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
| (Mark One) | ||
| (X) | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 27, 2003
OR
| ( ) | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 000-17157
NOVELLUS SYSTEMS, INC.
| California | 77-0024666 | |
| (State or other jurisdiction of | (I.R.S. Employer Identification | |
| incorporation of organization) | Number) |
4000 North First Street, San Jose, California 95134
(Address of principal executive offices including zip code)
(408) 943-9700
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES (X) NO ( )
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
YES (X) NO ( )
As of November 7, 2003, 152,336,058 shares of the Registrants common stock, no par value, were issued and outstanding.
NOVELLUS SYSTEMS, INC.
FORM 10-Q
QUARTER ENDED SEPTEMBER 27, 2003
TABLE OF CONTENTS
| Page | ||||||
Part I: Financial Information |
||||||
Item 1: Condensed Consolidated Financial Statements |
||||||
Condensed Consolidated Statements of Operations for the three and
nine months ended September 27, 2003 and September 28, 2002 |
3 | |||||
Condensed Consolidated Balance Sheets as of September 27, 2003
and December 31, 2002 |
4 | |||||
Condensed Consolidated Statements of Cash Flows for the nine months
ended September 27, 2003 and September 28, 2002 |
5 | |||||
Notes to Condensed Consolidated Financial Statements |
6 | |||||
Item 2: Managements Discussion and Analysis of Financial Condition
and Results of Operations |
12 | |||||
Item 3: Quantitative and Qualitative Disclosures About Market Risk |
21 | |||||
Item 4: Controls and Procedures |
21 | |||||
Part II: Other Information |
23 | |||||
Item 1: Legal Proceedings |
23 | |||||
Item 5: Other Information |
25 | |||||
Item 6: Exhibits and Reports on Form 8-K |
26 | |||||
Signatures |
27 | |||||
2
PART I: FINANCIAL INFORMATION
ITEM 1: CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOVELLUS SYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(unaudited)
| Three Months Ended | Nine Months Ended | ||||||||||||||||||
| September 27, | September 28, | September 27, | September 28, | ||||||||||||||||
| 2003 | 2002 | 2003 | 2002 | ||||||||||||||||
Net sales |
$ | 221,099 | $ | 230,495 | $ | 698,559 | $ | 622,321 | |||||||||||
Cost of sales |
162,323 | 121,113 | 424,647 | 339,846 | |||||||||||||||
Gross profit |
58,776 | 109,382 | 273,912 | 282,475 | |||||||||||||||
Operating expenses: |
|||||||||||||||||||
Selling, general and administrative |
40,123 | 43,143 | 127,197 | 117,307 | |||||||||||||||
Research and development |
59,858 | 58,248 | 173,374 | 171,021 | |||||||||||||||
Restructuring and other charges |
18,529 | | 18,529 | 3,273 | |||||||||||||||
Bad debt recovery |
| | | (7,662 | ) | ||||||||||||||
Total operating expenses |
118,510 | 101,391 | 319,100 | 283,939 | |||||||||||||||
Operating (loss) income |
(59,734 | ) | 7,991 | (45,188 | ) | (1,464 | ) | ||||||||||||
Interest and other income, net |
2,722 | 8,926 | 13,911 | 38,443 | |||||||||||||||
Write-off of unamortized debt issuance costs |
| (17,047 | ) | | (17,047 | ) | |||||||||||||
(Loss) income before income taxes and cumulative effect
of a change in accounting principle |
(57,012 | ) | (130 | ) | (31,277 | ) | 19,932 | ||||||||||||
Benefit for income taxes |
(22,224 | ) | (4,213 | ) | (15,791 | ) | | ||||||||||||
(Loss) income before cumulative effect of a change
in accounting principle |
(34,788 | ) | 4,083 | (15,486 | ) | 19,932 | |||||||||||||
Cumulative effect of a change in accounting
principle, net of tax |
(62,780 | ) | | (62,780 | ) | | |||||||||||||
Net (loss) income |
$ | (97,568 | ) | $ | 4,083 | $ | (78,266 | ) | $ | 19,932 | |||||||||
Net (loss) income per share: |
|||||||||||||||||||
Basic |
|||||||||||||||||||
(Loss) income before cumulative effect of a change
in accounting principle |
$ | (0.23 | ) | $ | 0.03 | $ | (0.10 | ) | $ | 0.14 | |||||||||
Cumulative effect of a change in accounting principle |
(0.41 | ) | | (0.42 | ) | | |||||||||||||
Basic net (loss) income per share |
$ | (0.64 | ) | $ | 0.03 | $ | (0.52 | ) | $ | 0.14 | |||||||||
Diluted |
|||||||||||||||||||
(Loss) income before cumulative effect of a change
in accounting principle |
$ | (0.23 | ) | $ | 0.03 | $ | (0.10 | ) | $ | 0.13 | |||||||||
Cumulative effect of a change in accounting principle |
(0.41 | ) | | (0.42 | ) | | |||||||||||||
Diluted net (loss) income per share |
$ | (0.64 | ) | $ | 0.03 | $ | (0.52 | ) | $ | 0.13 | |||||||||
Shares used in basic per share calculation |
151,280 | 143,691 | 150,221 | 144,355 | |||||||||||||||
Shares used in diluted per share calculation |
151,280 | 146,094 | 150,221 | 149,257 | |||||||||||||||
See accompanying notes to condensed consolidated financial statements.
3
NOVELLUS SYSTEMS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
| September 27, | December 31, | |||||||||
| 2003 | 2002 * | |||||||||
| (unaudited) | ||||||||||
ASSETS |
||||||||||
Current assets: |
||||||||||
Cash and cash equivalents |
$ | 529,483 | $ | 615,844 | ||||||
Short-term investments |
448,030 | 403,808 | ||||||||
Accounts receivable, net |
221,308 | 192,862 | ||||||||
Inventories |
200,773 | 257,358 | ||||||||
Deferred tax assets, net |
155,221 | 119,699 | ||||||||
Prepaid and other current assets |
19,572 | 44,363 | ||||||||
Total current assets |
1,574,387 | 1,633,934 | ||||||||
Property and equipment, net |
513,241 | 179,926 | ||||||||
Notes receivable |
| 397,429 | ||||||||
Goodwill |
172,893 | 163,136 | ||||||||
Intangible and other assets |
57,315 | 119,569 | ||||||||
Total assets |
$ | 2,317,836 | $ | 2,493,994 | ||||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||||
Current liabilities: |
||||||||||
Accounts payable |
$ | 69,003 | $ | 71,218 | ||||||
Accrued payroll and related expenses |
33,766 | 36,748 | ||||||||
Accrued warranty |
30,122 | 31,002 | ||||||||
Other accrued liabilities |
49,018 | 56,522 | ||||||||
Income taxes payable |
8,731 | 14,070 | ||||||||
Deferred profit |
40,477 | 55,613 | ||||||||
Current obligations under lines of credit |
3,164 | | ||||||||
Convertible subordinated notes |
| 116,437 | ||||||||
Total current liabilities |
234,281 | 381,610 | ||||||||
Deferred tax liabilities |
| 19,502 | ||||||||
Other liabilities |
48,251 | 37,194 | ||||||||
Total liabilities |
282,532 | 438,306 | ||||||||
Shareholders equity: |
||||||||||
Common stock |
1,543,604 | 1,487,281 | ||||||||
Retained earnings |
491,759 | 570,153 | ||||||||
Accumulated other comprehensive loss |
(59 | ) | (1,746 | ) | ||||||
Total shareholders equity |
2,035,304 | 2,055,688 | ||||||||
Total liabilities and shareholders equity |
$ | 2,317,836 | $ | 2,493,994 | ||||||
| * | Amounts as of December 31, 2002 are derived from the December 31, 2002 audited financial statements. |
See accompanying notes to condensed consolidated financial statements.
4
NOVELLUS SYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
| Nine Months Ended | |||||||||||
| September 27, | September 28, | ||||||||||
| 2003 | 2002 | ||||||||||
Cash flows from operating activities: |
|||||||||||
Net (loss) income |
$ | (78,266 | ) | $ | 19,932 | ||||||
Adjustments to reconcile net (loss) income to net cash
provided by operating activities: |
|||||||||||
Write-off of unamortized debt issuance costs |
| 17,047 | |||||||||
Gain on sale of an investment |
| (4,602 | ) | ||||||||
Non-cash portion of restructuring and other charges |
51,895 | | |||||||||
Loss on extinguishment of debt |
616 | | |||||||||
Bad debt recovery |
| (7,662 | ) | ||||||||
Depreciation and amortization |
47,962 | 32,292 | |||||||||
Cumulative effect of a change in accounting principle, net of tax benefit |
62,780 | | |||||||||
Deferred income taxes |
(17,396 | ) | (6,278 | ) | |||||||
Stock-based compensation |
3,055 | 4,861 | |||||||||
Income tax benefits from employee stock option plans |
| 17,313 | |||||||||
Changes in operating assets and liabilities: |
|||||||||||
Accounts receivable |
(28,446 | ) | 3,345 | ||||||||
Inventories |
12,854 | 5,434 | |||||||||
Prepaid and other current assets |
15,057 | 68,683 | |||||||||
Accounts payable |
(2,215 | ) | 2,093 | ||||||||
Accrued payroll and related expenses |
(2,982 | ) | 854 | ||||||||
Accrued warranty |
(880 | ) | (7,802 | ) | |||||||
Other accrued liabilities |
(7,880 | ) | 2,385 | ||||||||
Income taxes payable |
(5,339 | ) | 3,650 | ||||||||
Deferred profit |
(15,136 | ) | 26,560 | ||||||||
Net cash provided by operating activities |
35,679 | 178,105 | |||||||||
Cash flows from investing activities: |
|||||||||||
Proceeds from sales and maturities of short-term investments |
1,102,611 | 548,461 | |||||||||
Purchases of short-term investments |
(1,147,409 | ) | (627,221 | ) | |||||||
Proceeds from sales and maturities of restricted short-term investments |
| 2,146,931 | |||||||||
Purchases of restricted short-term investments |
| (1,186,362 | ) | ||||||||
Participation in synthetic leases |
| (177,458 | ) | ||||||||
Capital expenditures |
(23,867 | ) | (21,412 | ) | |||||||
Decrease in other assets |
7,373 | 1,834 | |||||||||
Net cash (used in) provided by investing activities |
(61,292 | ) | 684,773 | ||||||||
Cash flows from financing activities: |
|||||||||||
Repayments of convertible subordinated notes |
(117,053 | ) | (879,750 | ) | |||||||
Proceeds from employee stock compensation plans |
53,180 | 39,882 | |||||||||
Proceeds from (payments on) lines of credit, net |
3,164 | (24,544 | ) | ||||||||
Repurchase of common stock |
(39 | ) | (75,370 | ) | |||||||
Net cash used in financing activities |
(60,748 | ) | (939,782 | ) | |||||||
Net decrease in cash and cash equivalents |
(86,361 | ) | (76,904 | ) | |||||||
Cash and cash equivalents at the beginning of the period |
615,844 | 550,640 | |||||||||
Cash and cash equivalents at the end of the period |
$ | 529,483 | $ | 473,736 | |||||||
See accompanying notes to condensed consolidated financial statements.
5
NOVELLUS SYSTEMS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. BASIS OF PRESENTATION AND STOCK-BASED COMPENSATION
Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to the Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. The interim financial information is unaudited and does not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 27, 2003 are not necessarily indicative of the results that may be expected for the year ending December 31, 2003. For further information, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2002.
On December 6, 2002, we acquired SpeedFam-IPEC, Inc., a global supplier of chemical mechanical planarization (CMP) systems used in the fabrication of advanced copper interconnects. The acquisition was accounted for as a purchase business combination and qualifies as a tax-free reorganization under IRS regulations. Our condensed consolidated financial statements for the three and nine months ended September 27, 2003 include the financial position, results of operations and cash flows of SpeedFam-IPEC.
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosures of contingent assets and liabilities. We evaluate our estimates on an ongoing basis, including those related to revenue recognition, allowance for doubtful accounts, inventory valuation, deferred tax assets, property and equipment, goodwill and other intangible assets, warranty obligations, restructuring and impairment charges, contingencies and litigation, and stock-based compensation. We base our estimates on historical experience and on other assumptions that are believed to be reasonable under the current circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Our intent is to accurately state our assets given facts known at the time of valuation. Our assumptions may prove incorrect as facts change in the future. Actual results may differ from these estimates under different assumptions or conditions.
The accompanying condensed consolidated financial statements include our accounts and the accounts of our wholly-owned subsidiaries after the elimination of all significant intercompany account balances and transactions.
We operate primarily in one segment, the manufacturing, marketing, and servicing of semiconductor wafer fabrication equipment. Since we operate in one segment, all financial information required by Statement of Financial Accounting Standards No. 131, Disclosures About Segments of an Enterprise and Related Information, or SFAS No. 131, is included in the condensed consolidated financial statements.
Stock-Based Compensation
We account for stock-based employee compensation using the intrinsic value method under Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees, and have adopted the disclosure-only provisions of SFAS No. 123, Accounting for Stock-Based Compensation, as amended by SFAS No. 148, Accounting for Stock-Based Compensation Transition and Disclosures. Accordingly, no expense has been recognized for options granted to employees at fair value. We amortize deferred stock-based compensation on the graded vesting method over the vesting periods of the applicable stock purchase rights and stock options, generally four years. The graded vesting method provides for vesting of portions of the overall awards at interim dates and results in greater expense recorded in earlier years than the straight-line method.
SFAS No. 123 requires the use of option pricing models that were not developed for use in valuing employee stock options. The Black-Scholes option-pricing model was developed for use in estimating the fair value of short-lived exchange-traded
6
options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the options expected life and the price volatility of the underlying stock. Because the Companys employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in the opinion of management, the existing models do not necessarily provide a reliable single measure of the fair value of employee stock options.
Had compensation expense been determined based on the fair value at the grant date for awards, consistent with the provisions of SFAS No. 123, we would have reported pro forma net loss and net loss per share as follows (in thousands, except per share data):
| Three Months Ended | Nine Months Ended | ||||||||||||||||
| September 27, | September 28, | September 27, | September 28, | ||||||||||||||
| 2003 | 2002 | 2003 | 2002 | ||||||||||||||
Net (loss) income as reported |
$ | (97,568 | ) | $ | 4,083 | $ | (78,266 | ) | $ | 19,932 | |||||||
Add: |
|||||||||||||||||
Intrinsic value method expense included in
reported net income, net of related tax effects |
303 | 269 | 1,737 | 782 | |||||||||||||
Less: |
|||||||||||||||||
Fair value method expense, net of
related tax effects |
(13,333 | ) | (18,631 | ) | (48,899 | ||||||||||||